Clinical trial Recruiting at 1 site Interventional Ages 60 and up

WeChat group program to reduce social frailty in older adults with heart failure

Official title: The Effects of "Social Optimization Chat for Interactive Learning for Heart Failure" (SOCIAL_HF) on Improving Social Frailty: A Randomized Controlled Trial

Run by The University of Hong Kong · NCT07234565 · Data updated 2026-11-12

This 6-week WeChat group program tries to improve social frailty, self-care, and social participation in people aged 60 and older who have heart failure.

More Heart Failure trials

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment208 (estimated)
SponsorThe University of Hong Kong
Academic / other
Locations3 sites (Shanghai and 2 other locations)
StatusRecruiting
StartedSeptember 15, 2025
Main results expectedSeptember 30, 2027
Study endsSeptember 30, 2027
Registry record updatedOctober 15, 2026
Trial IDNCT07234565 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are community-dwelling adults aged 60 or older with a clinical diagnosis of heart failure for at least 6 months, evidence of social pre-frailty or frailty (SFS-8 score ≥ 2), and a smartphone with experience using WeChat who can read and write Chinese.

Probably not a fit

Patients with severe cognitive impairment or dementia, known mental illness, significant communication or sensory barriers (including illiteracy or inability to use WeChat), or those already in other intervention studies are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a two-arm, single-blind randomized controlled trial that will randomize about 208 community-dwelling older adults with heart failure to either a 6-week interactive WeChat group program (SOCIAL_HF) or usual care with a self-study heart failure self-care manual. The SOCIAL_HF intervention includes weekly WeChat video meetings for peer sharing and collaborative tasks, daily health task check-ins, and online self-care resources. The trial includes a feasibility phase followed by a larger-scale RCT, with recruitment conducted via face-to-face screening at multiple hospitals in Shanghai and 1:1 random allocation. Primary outcomes focus on social frailty, while secondary outcomes include self-care ability, social participation, and perceived social support.

Why it matters

Potential benefit: If successful, the program could reduce social frailty and improve self-care, social participation, and perceived social support, leading to better quality of life for older adults with heart failure.

How similar studies have gone: Digital peer-support and self-management programs have shown some benefit for chronic disease self-care, but WeChat-based interventions specifically targeting social frailty in heart failure remain limited and relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. 60 years old and above;
2. Live in the community;
3. a definitive diagnosis of heart failure based on the Framingham Heart Failure Diagnostic Criteria;
4. a diagnosis of heart failure for 6 months or longer;
5. evidence of social pre-frailty or frailty, determined by the SFS-8 score ≥ 2; (6) possession of a smartphone and experience using WeChat;

(7) be able to read and write Chinese.

Exclusion Criteria:

1. severe cognitive impairment or dementia;
2. known mental illnesses;
3. any communication barriers may hinder participation in SOCIAL\_HF, such as illiteracy, reading disabilities, speak local dialect only, and difficulties in language comprehension;
4. any sensory impairments that may affect learning or interaction with others on WeChat, including untreated severe hearing loss and vision impairments;
5. are currently participating in other intervention studies.

Where it's running

  • Shanghai Jiao Tong University School of Medicine Affiliated Songjiang Hospital
    Shanghai, China
    Recruiting
  • Fudan University Affiliated Huadong Hospital
    Shanghai, China
    Not yet recruiting
  • Shanghai Baoshan District Integrated Traditional Chinese and Western Medicine Hospital
    Shanghai, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.